News & Analysis on Clinical Trial Services & Contract Research And Development
US-based BioDuro and The National Center for Safety Evaluation of Drugs (NCSED) in Beijing have received full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC).
A new type of latex glove developed by Yulex Corp that is less allergenic for medical and research staff has been given a green light by the US Food and Drug Administration (FDA).
In this week's review of activity within the preclinical research services arena, news has emerged involving MIR Preclinical Services, Commonwealth Biotechnologies and Innogenetics.
Quintiles Transnational has heralded the results of an independently conducted study of clinical investigator sites across Europe that saw the firm rate the highest overall in terms of satisfaction.
Swedish firm Recipharm is concentrating its efforts on becoming one of the leading contract development and manufacturing organisations (CDMOs).
Lab901 has raised £3.5m in funding, which will go towards expanding its sales efforts and new products for RNA and Protein Electrophoresis - a market that is currently worth $1.3bn worldwide and expected to increase to over $1.6bn.
Dutch chemical group DSM has acquired Polymer Technology Group (PTG) and predicted its best financial year to date following organic sales growth of 14 per cent for the first quarter.
UK researchers have started developing a 'lung in a test tube', that could aid research into respiratory diseases such as asthma and allergy and reduce the need for animal testing.
Invitrogen's first-quarter profits were nearly double those it recorded in the first-quarter of 2007.The maker of kits used for cloning enjoyed growth, driven by sharp increases in sales for drug discovery and research.